Back to MORGAN STANLEY MORGAN STANLEY

MYGNMYGN
Showing 8 of 9 quarters

Position history for MORGAN STANLEYMORGAN STANLEY's holdings in MYRIAD GENETICS INC

MORGAN STANLEY holds 2.5M shares of MYGN (MYRIAD GENETICS INC), worth $14.2M as of 2026-Q2. The position was decreased (-21.7% shares). MYGN represents 0.0% of MORGAN STANLEY's portfolio.

Current Value

$14.2M

Current Shares

2.5M

Total Value Change

-$10M

Total Shares Change

+1.6M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
2.5M
-21.7%
$14.2M0.0%$5.71
0
2026-Q1
Decreased
3.2M
-12.2%
$14.3M0.0%$5.29
0
2025-Q4
Decreased
3.6M
-0.3%
$22.2M0.0%$6.17
0
2025-Q3
Decreased
3.6M
-20.6%
$26.2M0.0%$7.24
0
2025-Q2
Increased
4.6M
+182.1%
$24.2M0.0%$5.25
46
2025-Q1
Increased
1.6M
+25.6%
$14.3M0.0%$8.88
35
2024-Q4
Increased
1.3M
+45.9%
$17.6M0.0%$13.63
38
2024-Q3
Decreased
880,987
-35.8%
$24.1M0.0%$26.46
0

Other major holders of MYGN: BNP PARIBAS FINANCIAL MARKETS, BlackRock Finance, Inc., BAILLIE GIFFORD & CO, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used